Automated Hovering for Congestive Heart Failure Patients (EMPOWER)
Heart Failure
About this trial
This is an interventional health services research trial for Heart Failure focused on measuring Remote monitoring, Incentives
Eligibility Criteria
Inclusion Criteria:
- Patients with a recent University of Pennsylvania Health System hospital (UPHS) discharge of congestive heart failure (CHF) aged 18-80 who will receive follow-up in a UPHS outpatient clinic.
Exclusion Criteria:
- Patients will be excluded if they will not or cannot give consent or have a markedly shortened life expectancy (listed for heart transplant,have a ventricular assist device, are inotrope dependent, metastatic cancer, or dementia)
- end-stage renal disease (since they may not produce urine and be responsive to diuretics).
- on dialysis
- Heart failure managed with a CardioMEMS monitor
- Receiving another remote monitoring/telemedicine intervention
- Receiving follow up care outside of UPHS
Sites / Locations
- University of Pennsylvania
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Intervention
Control
Participants will be (1) given an electronic pill bottle for their diuretic and a Bluetooth scale; (2) asked to provide the coordinator with name and contact information of a family member or friend to serve as a support partner; (3) will be assigned a 2-digit number to be used as part of the lottery-based engagement incentives in which eligibility to win will be conditional on medication adherence and registering a weight measurement; and, (4) will determine their preferences for Way to Health platform communication methods during the study.(5) Research coordinators to remotely monitor weight gain thresholds and add alert into the participant's electronic health record for verified weight gain
Participants will receive usual care.